| CEO: | Sean M. Smith |
| CFO: | Alexander John Abrey |
| Non-Executive Chairman: | Lykele van der Broek |
| Non-Executive Dir: | Robin James Scott Cridland |
| Address: | 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, United Kingdom, OX14 4RQ |
| Website: | http://www.edenresearch.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0001646941 |
| Currency | UK Pounds |
| Share Price | 3.30p |
| Change Today | -0.15p |
| % Change | -4.35 % |
| 52 Week High | 4.80 |
| 52 Week Low | 2.10 |
| Volume | 159,984 |
| Shares Issued | 803.36m |
| Market Cap | £26.51m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:12 | 20,000 @ 3.39p |
| 14:59 | 20,000 @ 3.39p |
| 14:25 | 19,000 @ 3.22p |
| 14:00 | 19,852 @ 3.40p |
| 13:46 | 6,737 @ 3.20p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research